Cdc14b Phosphatase Inhibitors
Chemical inhibitors of Cdc14b Phosphatase encompass a range of compounds that disrupt its activity through various mechanisms. Brefeldin A, for example, dismantles the structural integrity of the Golgi apparatus, a cellular locale where Cdc14b Phosphatase operates. This disassembly precludes Cdc14b Phosphatase from reaching its functional destination, thus impeding its role in cell cycle regulation. Similarly, Okadaic Acid, Calyculin A, Cantharidin, Tautomycin, Endothall, Fostriecin, Microcystin-LR, and Norcantharidin all inhibit protein phosphatases. Their modes of action, although distinct, converge on the common outcome of hampering the dephosphorylation capability of Cdc14b Phosphatase. For instance, Okadaic Acid and Calyculin A directly challenge Cdc14b Phosphatase by competitive inhibition, effectively blocking the active site available for dephosphorylation of target substrates. Cantharidin and its analog Norcantharidin exert their effects by obstructing the phosphatase activity of Cdc14b Phosphatase, thereby preventing the catalytic process needed for cell cycle progression.
Further extending the arsenal of inhibitors, Salubrinal and Cyclosporin A target distinct enzymes but achieve an indirect suppression of Cdc14b Phosphatase activity. Salubrinal's selective inhibition of eIF2α dephosphorylation indirectly stalls the enzymatic cascade that may involve Cdc14b Phosphatase, while Cyclosporin A's inhibition of calcineurin affects broader dephosphorylation pathways which can include those mediated by Cdc14b Phosphatase. Cerulenin employs an alternative strategy by altering the lipid composition of the cell, which can affect membrane-associated functions and the subcellular localization of Cdc14b Phosphatase, leading to a functional inhibition. Each compound, through its unique interaction with cellular pathways, ensures that Cdc14b Phosphatase is hindered from performing its critical role in the dephosphorylation events that are crucial for cell cycle control and regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus, where Cdc14b Phosphatase is known to localize and function. This disruption can inhibit Cdc14b Phosphatase by preventing its proper localization and therefore its function in cell cycle regulation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
As a potent inhibitor of serine/threonine phosphatases, Okadaic Acid can inhibit phosphatases similar to Cdc14b Phosphatase, leading to a decrease in Cdc14b Phosphatase activity by competitive inhibition or by altering the phosphatase substrate availability. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A is an inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), and could inhibit Cdc14b Phosphatase by a similar mechanism of action, which is by inhibiting the dephosphorylation process that Cdc14b Phosphatase is responsible for. | ||||||
Cantharidin | 56-25-7 | sc-201321 sc-201321A | 25 mg 100 mg | $89.00 $279.00 | 6 | |
Cantharidin inhibits protein phosphatases and could inhibit Cdc14b Phosphatase by blocking its phosphatase activity, thus preventing the dephosphorylation of its specific substrates involved in cell cycle control. | ||||||
Endothall | 145-73-3 | sc-201325 sc-201325A | 20 mg 100 mg | $49.00 $203.00 | 1 | |
Endothall acts as a protein phosphatase inhibitor and is likely to inhibit Cdc14b Phosphatase by impairing its ability to dephosphorylate its substrates, thereby inhibiting its function in cell cycle progression. | ||||||
Fostriecin | 87860-39-7 | sc-202160 | 50 µg | $265.00 | 9 | |
Fostriecin selectively inhibits PP2A and PP4, which are serine/threonine phosphatases. By this mechanism, Fostriecin can inhibit Cdc14b Phosphatase activity by preventing dephosphorylation processes that Cdc14b Phosphatase is known to mediate. | ||||||
Norcantharidin | 29745-04-8 | sc-280719 | 5 g | $113.00 | 2 | |
Norcantharidin is a demethylated analog of cantharidin and acts as an inhibitor of serine/threonine phosphatases. It can inhibit Cdc14b Phosphatase by similarly inhibiting its phosphatase activity and impairing the cell cycle regulation. | ||||||
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $34.00 $104.00 | 87 | |
Salubrinal is a selective inhibitor of eIF2α dephosphorylation and indirectly inhibits related phosphatases. Through this inhibition, Salubrinal can prevent the dephosphorylation function of Cdc14b Phosphatase, thus inhibiting its activity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A primarily inhibits calcineurin, and through this action, it can indirectly inhibit Cdc14b Phosphatase by affecting pathways that require dephosphorylation events which Cdc14b Phosphatase could be involved in. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
Cerulenin, an inhibitor of fatty acid synthase, can indirectly affect the localization and function of Cdc14b Phosphatase by altering cellular lipid composition and membrane-associated functions where Cdc14b Phosphatase may participate. | ||||||